GenMont BiotechTPE:3164 83 Days Inventory is 173.01 as of Dec. 2025, which is 14% above its 10-year median of 151.78. GuruFocus rates TPE:3164 with a GF Score™ of 83/100 and a GF Value™ of NT$26.24 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 637 Biotechnology companies, GenMont Biotech ranks better than 51.49% on this metric.
The historical rank and industry rank for GenMont Biotech's Days Inventory or its related term are showing as below:
TPE:3164'
s Days Inventory Range Over the Past 10 Years
Min: 91.72 Med: 151.78 Max: 245.03
Current: 177.39
During the past 13 years, GenMont Biotech's highest Days Inventory was 245.03. The lowest was 91.72. And the median was 151.78.
TPE:3164's Days Inventory is ranked better than 51.49% of 637
companies
in the Biotechnology industry
Industry Median: 183.23
vs TPE:3164: 177.39
GenMont Biotech's Days Inventory
declined
from Dec. 2024 (175.49) to Dec. 2025 (173.01).
Inventory Turnover measures how fast the company turns over its inventory within a year.
GenMont Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.53.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GenMont Biotech's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.72.
GenMont Biotech (TPE:3164) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
GenMont Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GenMont Biotech's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
GenMont Biotech Days Inventory Related Terms
GenMont Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for GenMont Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:3164 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, GenMont Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GenMont Biotech Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GenMont Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where GenMont Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenMont Biotech (TPE:3164) has a Days Inventory of 173.01 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GenMont Biotech and its competitors. This is 14% above median its historical median of 151.78. Over the past decade, GenMont Biotech's Days Inventory has ranged from 91.72 to 245.03. According to the industry distribution chart, GenMont Biotech ranks #309 out of 637 companies in the Biotechnology industry, placing it in the top 48.5%.
Is GenMont Biotech's Days Inventory too high?
GenMont Biotech's current Days Inventory of 173.01 is 14% above median its 10-year median of 151.78. Over the past 10 years, this metric has ranged from a low of 91.72 to a high of 245.03. The Biotechnology industry median Days Inventory is 183.23. GenMont Biotech's value of 173.01 is 5.6% below this industry median. Based on the distribution chart, GenMont Biotech ranks #309 out of 637 companies in the Biotechnology industry, which is above the industry midpoint. Overall, GenMont Biotech has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GenMont Biotech's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GenMont Biotech ranks #309 out of 637 companies for Days Inventory. This puts GenMont Biotech in the upper half of its industry. The industry median Days Inventory is 183.23. GenMont Biotech's value of 173.01 is 5.6% below this benchmark. Historically, GenMont Biotech's own Days Inventory has ranged from 91.72 to 245.03 over the past decade. While the company's 10-year median is 151.78 vs. the industry median of 183.23, GenMont Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GenMont Biotech's current Days Inventory of 173.01 is 5.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GenMont Biotech and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GenMont Biotech's current Days Inventory is 173.01, which is 14% above median its own 10-year median of 151.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenMont Biotech stock overvalued right now?
Based on GuruFocus' analysis, GenMont Biotech (TPE:3164) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$26.24, compared to a current price of NT$16.45 — trading 37.3% below its estimated fair value. The current Days Inventory is 173.01, which is 14% above median its 10-year median of 151.78 and 5.6% below the Biotechnology industry median of 183.23. GenMont Biotech's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For GenMont Biotech (TPE:3164), the current Days Inventory is 173.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GenMont Biotech (TPE:3164) Overvalued in 2026?
Based on GuruFocus' analysis, GenMont Biotech stock appears to be undervalued.
The current stock price of NT$16.45 is trading 37.3% below its estimated GF Value™ of NT$26.24.
GuruFocus considers GenMont Biotech to be Significantly Undervalued.
Key valuation signals for TPE:3164:
Days Inventory: 173.01 (14% above median its 10-year median of 151.78)
GF Value™: NT$26.24 vs. price of NT$16.45 (37.3% below fair value)
Industry Position: 5.6% below the Biotechnology median (#309 of 637)
No single metric tells the full story. See the TPE:3164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, its single operating segment.
83GF Score
Get the complete analysis for TPE:3164
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3164 has been successfully added to your 
